Seth M. Pransky

Pediatric Otolaryngology | Otolaryngology

3262 Holiday Ct Ste 204
La Jolla, CA 92037

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Updated Practice Patterns for Adjuvant Treatment of Recurrent Laryngeal Papillomatosis.

Updated Practice Patterns for Adjuvant Treatment of Recurrent Laryngeal Papillomatosis.

Journal: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery

Published: December 10, 2025

In Response to A Clinical Consensus Statement on Pulmonary Recurrent Respiratory Papillomatosis.

In Response to A Clinical Consensus Statement on Pulmonary Recurrent Respiratory Papillomatosis.

Journal: The Laryngoscope

Published: October 15, 2025

A Clinical Consensus Statement on Pulmonary Recurrent Respiratory Papillomatosis.

A Clinical Consensus Statement on Pulmonary Recurrent Respiratory Papillomatosis.

Journal: The Laryngoscope

Published: April 07, 2025

DNA Immunotherapy (INO-3107) Results in Long-Term Surgery Reduction in RRP.

DNA Immunotherapy (INO-3107) Results in Long-Term Surgery Reduction in RRP.

Journal: The Laryngoscope

Published: April 03, 2025

DNA immunotherapy for recurrent respiratory papillomatosis (RRP): phase 1/2 study assessing efficacy, safety, and immunogenicity of INO-3107.

DNA immunotherapy for recurrent respiratory papillomatosis (RRP): phase 1/2 study assessing efficacy, safety, and immunogenicity of INO-3107.

Journal: Nature communications

Published: August 01, 2024

International Pediatric Otolaryngology Group: Consensus guidelines on the diagnosis and management of non-tuberculous mycobacterial cervicofacial lymphadenitis.

International Pediatric Otolaryngology Group: Consensus guidelines on the diagnosis and management of non-tuberculous mycobacterial cervicofacial lymphadenitis.

Journal: International journal of pediatric otorhinolaryngology

Published: December 27, 2022

Interim Results of a Phase 1/2 Open-Label Study of INO-3107 for HPV-6 and/or HPV-11-Associated Recurrent Respiratory Papillomatosis.

Interim Results of a Phase 1/2 Open-Label Study of INO-3107 for HPV-6 and/or HPV-11-Associated Recurrent Respiratory Papillomatosis.

Journal: The Laryngoscope

Published: December 22, 2022

Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why?

Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why?

Journal: The Laryngoscope

Published: February 14, 2022

International Pediatric Otolaryngology Group (IPOG) survey: Efforts to avoid complications in home tracheostomy care.

International Pediatric Otolaryngology Group (IPOG) survey: Efforts to avoid complications in home tracheostomy care.

Journal: International journal of pediatric otorhinolaryngology

Published: December 11, 2020

Systemic Bevacizumab for Treatment of Respiratory Papillomatosis: International Consensus Statement.

Systemic Bevacizumab for Treatment of Respiratory Papillomatosis: International Consensus Statement.

Journal: The Laryngoscope

Published: October 21, 2020

International Pediatric Otolaryngology Group (IPOG) management recommendations: Pediatric tracheostomy decannulation.

International Pediatric Otolaryngology Group (IPOG) management recommendations: Pediatric tracheostomy decannulation.

Journal: International journal of pediatric otorhinolaryngology

Published: September 26, 2020

Undifferentiated recurrent fevers in pediatrics are clinically distinct from PFAPA syndrome but retain an IL-1 signature.

Undifferentiated recurrent fevers in pediatrics are clinically distinct from PFAPA syndrome but retain an IL-1 signature.

Journal: Clinical immunology (Orlando, Fla.)

Published: August 01, 2020

Showing 1-12 of 28

Last Updated: 09/26/2026